• DNDi_Logo_No-Tagline_Full Colour
  • Our work
    • Diseases
      • Sleeping sickness
      • Visceral leishmaniasis
      • Cutaneous leishmaniasis
      • Chagas disease
      • Filaria: river blindness
      • Mycetoma
      • Paediatric HIV
      • Cryptococcal meningitis
      • Hepatitis C
      • Dengue
      • Pandemic preparedness
      • Antimicrobial resistance
    • Research & development
      • R&D portfolio & list of projects
      • Drug discovery
      • Translational research
      • Clinical trials
      • Registration & access
      • Treatments delivered
    • Advocacy
      • Open and collaborative R&D
      • Transparency of R&D costs
      • Pro-access policies and IP
      • Children’s health
      • Gender equity
      • Climate change
      • AI and new technologies
  • Networks & partners
    • Partnerships
      • Our partners
      • Partnering with us
    • Global networks
      • Chagas Platform
      • Dengue Alliance
      • HAT Platform
      • LEAP Platform
      • redeLEISH Network
    • DNDi worldwide
      • DNDi Switzerland
      • DNDi DRC
      • DNDi Eastern Africa
      • DNDi Japan
      • DNDi Latin America
      • DNDi North America
      • DNDi South Asia
      • DNDi South-East Asia
  • News & resources
    • News & stories
      • News
      • Stories
      • Statements
      • Viewpoints
      • Social media
      • eNews Newsletter
    • Press
      • Press releases
      • In the media
      • Podcasts, radio & TV
    • Resources
      • Scientific articles
      • Our publications
      • Videos
    • Events
  • About us
    • About
      • Who we are
      • How we work
      • Our strategy
      • Our donors
      • Annual reports
      • Our prizes and awards
      • Our story: 20 years of DNDi
    • Our people
      • Our leadership
      • Our governance
      • Contact us
    • Work with us
      • Working at DNDi
      • Job opportunities
      • Requests for proposal
  • Donate
  • DNDi_Logo_No-Tagline_Full Colour
  • Our work
    • Diseases
      • Sleeping sickness
      • Visceral leishmaniasis
      • Cutaneous leishmaniasis
      • Chagas disease
      • Filaria: river blindness
      • Mycetoma
      • Paediatric HIV
      • Cryptococcal meningitis
      • Hepatitis C
      • Dengue
      • Pandemic preparedness
      • Antimicrobial resistance
    • Research & development
      • R&D portfolio & list of projects
      • Drug discovery
      • Translational research
      • Clinical trials
      • Registration & access
      • Treatments delivered
    • Advocacy
      • Open and collaborative R&D
      • Transparency of R&D costs
      • Pro-access policies and IP
      • Children’s health
      • Gender equity
      • Climate change
      • AI and new technologies
  • Networks & partners
    • Partnerships
      • Our partners
      • Partnering with us
    • Global networks
      • Chagas Platform
      • Dengue Alliance
      • HAT Platform
      • LEAP Platform
      • redeLEISH Network
    • DNDi worldwide
      • DNDi Switzerland
      • DNDi DRC
      • DNDi Eastern Africa
      • DNDi Japan
      • DNDi Latin America
      • DNDi North America
      • DNDi South Asia
      • DNDi South-East Asia
  • News & resources
    • News & stories
      • News
      • Stories
      • Statements
      • Viewpoints
      • Social media
      • eNews Newsletter
    • Press
      • Press releases
      • In the media
      • Podcasts, radio & TV
    • Resources
      • Scientific articles
      • Our publications
      • Videos
    • Events
  • About us
    • About
      • Who we are
      • How we work
      • Our strategy
      • Our donors
      • Annual reports
      • Our prizes and awards
      • Our story: 20 years of DNDi
    • Our people
      • Our leadership
      • Our governance
      • Contact us
    • Work with us
      • Working at DNDi
      • Job opportunities
      • Requests for proposal
  • Donate
Home > Press releases

Thailand’s Prince Mahidol Award honours Dr Bernard Pécoul, Founder of DNDi, for his service to public health

DNDi’s Executive Director joins a prestigious list of figures recognized for their contributions in fields of medicine and global health

Home > Press releases

Thailand’s Prince Mahidol Award honours Dr Bernard Pécoul, Founder of DNDi, for his service to public health

DNDi’s Executive Director joins a prestigious list of figures recognized for their contributions in fields of medicine and global health

Dr Bernard Pécoul
Bangkok/Kuala Lumpur — 12 Nov 2020
  • English
    • English
    • ไทย
    • 中文
    • اللغة العربية
    • Español
    • Português
    • 日本語

Dr Bernard Pécoul, Founder and Executive Director of the international not-for-profit medical research organization, Drugs for Neglected Diseases initiative (DNDi), has received Thailand’s Prince Mahidol Award 2020 for his contribution to furthering research for neglected diseases around the world.

The Prince Mahidol Award Foundation honours health and science leaders each year for their outstanding achievements in the fields of medicine and global public health. Former laureates include Dr Anthony Fauci (United States), Prof. Barry J. Marshall (Australia), Prof. Harald zur Hausen (Germany), Dr Satoshi Omura (Japan), and Prof. Tu Youyou (China).

‘It is an immense honour to join the list of health laureates of the Prince Mahidol Award,’ said Dr Pécoul. ‘This award also holds a special significance for me because I began my career in Thailand, where I was working in refugee camps 35 years ago. It was there that I saw first-hand the medical neglect that eventually led me and many partners to create DNDi.’

Dr Bernard Pécoul has led DNDi since its formation in 2003. When the medical humanitarian organization Médecins Sans Frontières (MSF) won the Nobel Peace Prize in 1999, it dedicated a portion of its prize award to exploring an innovative, alternative, not-for-profit model for developing drugs for hundreds of millions of neglected patients worldwide. DNDi was born. Its founding partners included MSF, the World Health Organization (WHO), and a group of five international public health institutions – the Malaysian Ministry of Health among them.

From left to right: Professor Supat Vanichakarn, M.D. Secretary-General of the Prince Mahidol Award Foundation under the Royal Patronage; Professor Dr Prasit Watanapa, M.D., Ph.D. Dean of Faculty of Medicine Siriraj Hospital, Mahidol University; Professor Vicharn Panich, M.D. Chairman of the International Award Committee of the Prince Mahidol Award Foundation; Mr. Tanee Sangrat, Director-General of the Department of Information, Ministry of Foreign Affairs, and Chairman of the Sub-Committee on Public Relations of the Prince Mahidol Award Foundation; Dr John R. MacArthur Regional Director, Southeast Asia (SEAS) Regional Office, US Centers for Disease Control and Prevention; Dr Taraneh Shojaei Regional Counsellor in Global Health, South-East Asia, at the French Embassy

‘The Prince Mahidol award is a well-deserved recognition of Dr Pécoul’s unwavering commitment to treating all people’s health as a matter of priority, no matter whether they are rich or poor,’ said Tan Sri Dr Noor Hisham Abdullah, Malaysian Director General of Health and DNDi Board Member. ‘An excellent example of that commitment bearing fruit is our close collaboration in Malaysia, where DNDi and the Ministry of Health are making tremendous progress expanding access to affordable treatment for people living with hepatitis C.’

Under Dr Pécoul’s leadership, DNDi has delivered eight new treatments for leishmaniasis, sleeping sickness, and Chagas disease – some of the world’s most neglected diseases – as well as for malaria and for children living with HIV. Working in partnership with hundreds of public and private actors around the world, the organization has developed a robust portfolio of projects spanning drug discovery, clinical research, and treatment access for these diseases, as well as for river blindness, mycetoma, and hepatitis C. Together with WHO, DNDi also launched the Global Antibiotic Research and Development Partnership (GARDP) in 2016, now an independent not-for-profit organization developing new treatments to fight drug-resistant infections that pose the greatest threat to health.

Dr Pécoul has devoted much of his career to advocating for access to medicines and creating an alternative R&D model driven exclusively by patients’ medical needs, not profits. He started his career in 1983 as a doctor with MSF, carrying out field missions in Africa, Latin America, and Asia. In 1988, he co-founded Epicentre, an MSF-affiliated NGO specializing in epidemiology. He became General Director of MSF France in 1991 and then served as Founding Director of the MSF Campaign for Access to Essential Medicines from 1998 to 2003.

‘Dr Pécoul firmly believes that low and middle-income countries can successfully build their own solutions to their own health problems, especially through the power of partnership and collaboration,’ said Jean-Michel Piedagnel, Director of DNDi’s South-East Asia Regional Office, based in Malaysia. ‘This award serves as a recognition of DNDi’s strong footprint in Thailand and South-East Asia, and we are certain it will contribute to support our work and strengthen our vital partnerships tackling hepatitis C, antimicrobial resistance, dengue fever, and other major public health challenges facing our region.’

Because of the current pandemic, this year’s laureates will be formally invited to attend the award ceremony in Thailand in 2022. The laureates will be invited soon to deliver online lectures about their achievements.

About DNDi

The Drugs for Neglected Diseases initiative (DNDi) is a not-for-profit R&D organization working to deliver new treatments for neglected patients, in particular for sleeping sickness, Chagas disease, leishmaniasis, river blindness, mycetoma, HIV, and hepatitis C virus. DNDi’s ambition is to help enable widespread access to HCV treatment through the development and registration of affordable, safe, and efficacious pan-genotypic direct-acting antivirals (DAAs), and through advocacy for the policy change and political will needed to remove barriers to access to DAAs globally.

About the Prince Mahidol Award Foundation:

The Prince Mahidol Award Foundation was established by the permission of His Majesty the King Bhumibol Adulyadej, in accordance with the proposal of Faculty of Medicine, Siriraj Hospital, in commemoration of the Centenary Birthday Anniversary of His Royal Highness Prince Mahidol of Songkla on 1 January 1992. The Foundation was established in honour of His Royal Highness and in recognition of his exemplary contribution as “The Father of Modern Medicine and Public Health of Thailand.”

Media contacts

DNDi South-East Asia regional office
Molly Jagpal
Mobile: +60 (0)12 546 8362
Email: mjagpal@dndi.org  

DNDi Geneva office
Frederic Ojardias
Email: fojardias@dndi.org

Photo credit: FBBVA, Prince Mahidol Foundation

Asia Thailand

Read, watch, share

Loading...
Statements
27 May 2025

DNDi interventions at the 78th World Health Assembly

Press releases
22 May 2025

Six African nations commit to eliminate deadly neglected disease visceral leishmaniasis

Videos
20 May 2025

The Children of the Sierra

Press releases
13 May 2025

First all-oral treatment for a rare but deadly strain of sleeping sickness now available and being used to treat patients in endemic countries in Africa

Statements
8 May 2025

DNDi’s briefing note for 78th World Health Assembly

Marco Krieger
News
30 Apr 2025

Message on the passing of Dr Marco Aurélio Krieger, Vice-President of Production and Innovation in Health, Fiocruz

Screening activities in village in Guinea
News
25 Apr 2025

Statements from Dr Luis Pizarro and Daisuke Imoto about the Hideyo Noguchi Africa Prize awarded to DNDi

Two man outside of a hospital talking with a nurse
Press releases
24 Apr 2025

Liverpool clinical trial aims to advance life-changing treatment for a deadly parasitic disease

VIEW ALL

Help neglected patients

To date, we have delivered thirteen new treatments, saving millions of lives.

Our goal is to deliver 25 new treatments in our first 25 years. You can help us get there. 

GIVE NOW
Linkedin-in Instagram Twitter Facebook-f Youtube
International non-profit developing safe, effective, and affordable treatments for the most neglected patients.

Learn more

  • Diseases
  • Neglected tropical diseases
  • R&D portfolio
  • Policy advocacy

Get in touch

  • Our offices
  • Contact us
  • Integrity Line

Support us

  • Donate
  • Subscribe to eNews

Work with us

  • Join research networks
  • Jobs
  • RFPs
  • Terms of Use   
  •   Acceptable Use Policy   
  •   Privacy Policy   
  •   Cookie Policy   
  •   Our policies   

  • Except for images, films and trademarks which are subject to DNDi’s Terms of Use, content on this site is licensed under a Creative Commons Attribution-NonCommercial-Share Alike 3.0 Switzerland License